Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6416) 6416
Publication (359) 359
Newsletter (84) 84
Book Review (62) 62
Magazine Article (14) 14
Book Chapter (9) 9
Newspaper Article (5) 5
Conference Proceeding (2) 2
Trade Publication Article (2) 2
Transcript (2) 2
Dissertation (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5402) 5402
female (3409) 3409
male (3368) 3368
adult (2378) 2378
methylprednisolone - therapeutic use (2335) 2335
middle aged (2273) 2273
methylprednisolone - administration & dosage (2024) 2024
methylprednisolone (2016) 2016
index medicus (1851) 1851
methylprednisolone - adverse effects (1801) 1801
aged (1299) 1299
treatment outcome (1147) 1147
corticosteroids (1089) 1089
adolescent (901) 901
drug therapy, combination (751) 751
child (660) 660
surgery (645) 645
therapy (645) 645
immunosuppressive agents - therapeutic use (626) 626
animals (619) 619
glucocorticoids - therapeutic use (614) 614
anti-inflammatory agents - therapeutic use (592) 592
glucocorticoids - administration & dosage (570) 570
glucocorticoids - adverse effects (566) 566
transplantation (549) 549
anti-inflammatory agents - administration & dosage (528) 528
time factors (519) 519
retrospective studies (511) 511
steroids (507) 507
medicine, general & internal (500) 500
follow-up studies (485) 485
clinical neurology (482) 482
anti-inflammatory agents - adverse effects (459) 459
immunology (456) 456
immunosuppressive agents - adverse effects (441) 441
risk factors (440) 440
care and treatment (437) 437
prospective studies (428) 428
drug therapy (399) 399
child, preschool (381) 381
dose-response relationship, drug (370) 370
drug administration schedule (352) 352
acute disease (350) 350
oncology (348) 348
rheumatology (337) 337
dexamethasone (331) 331
hematology (329) 329
methylprednisolone - analogs & derivatives (328) 328
dosage and administration (321) 321
pediatrics (320) 320
injections, intravenous (318) 318
research (317) 317
children (308) 308
double-blind method (306) 306
administration, oral (296) 296
medicine & public health (294) 294
pharmacology & pharmacy (289) 289
complications and side effects (288) 288
young adult (287) 287
recurrence (283) 283
double-blind (282) 282
health aspects (282) 282
management (281) 281
glucocorticoids (273) 273
immunosuppressive agents - administration & dosage (271) 271
adrenal cortex hormones - therapeutic use (269) 269
cyclophosphamide (267) 267
aged, 80 and over (266) 266
infusions, intravenous (264) 264
prednisone - therapeutic use (264) 264
disease (258) 258
urology & nephrology (253) 253
magnetic resonance imaging (245) 245
cyclosporine - therapeutic use (235) 235
diagnosis (235) 235
adrenal cortex hormones - adverse effects (234) 234
rats (232) 232
patients (228) 228
methylprednisolone - pharmacology (227) 227
abridged index medicus (226) 226
analysis (219) 219
prednisolone (216) 216
severity of illness index (208) 208
kidney transplantation (207) 207
cyclosporine (202) 202
biopsy (200) 200
multiple sclerosis (198) 198
prednisolone - administration & dosage (198) 198
infant (197) 197
cyclophosphamide - administration & dosage (196) 196
prednisone (196) 196
azathioprine - therapeutic use (192) 192
neurosciences (192) 192
immunosuppression (189) 189
prognosis (188) 188
adrenal cortex hormones - administration & dosage (187) 187
clinical trials (187) 187
prednisone - administration & dosage (187) 187
ophthalmology (185) 185
pulse therapy, drug (185) 185
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5857) 5857
Japanese (196) 196
German (126) 126
French (109) 109
Spanish (71) 71
Italian (33) 33
Chinese (25) 25
Polish (25) 25
Russian (14) 14
Danish (13) 13
Hungarian (9) 9
Turkish (8) 8
Portuguese (5) 5
Swedish (5) 5
Czech (4) 4
Dutch (4) 4
Finnish (4) 4
Korean (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Romanian (2) 2
Afrikaans (1) 1
Hebrew (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis
by Wüst, Simone and Tischner, Denise and John, Michael and Tuckermann, Jan P and Menzfeld, Christiane and Hanisch, Uwe-Karsten and van den Brandt, Jens and Lühder, Fred and Reichardt, Holger M
PLoS ONE, ISSN 1932-6203, 2009, Volume 4, Issue 12, pp. e8202 - e8202
Background: Dissociating glucocorticoid receptor (GR) ligands hold great promise for treating inflammatory disorders since it is assumed that they exert... 
APOPTOSIS | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | DNA-BINDING | REPRESSION | INFLAMMATION | TRANSACTIVATION | IN-VIVO | BIOLOGY | CENTRAL-NERVOUS-SYSTEM | METHYLPREDNISOLONE | T-CELLS | Organ Specificity - drug effects | Apoptosis - drug effects | Transcriptional Activation - drug effects | Myelin Sheath - drug effects | Receptors, Glucocorticoid - metabolism | Acetates | Myelin Sheath - metabolism | Dose-Response Relationship, Drug | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Tyramine - analogs & derivatives | Disease Models, Animal | Fibroblasts - metabolism | Solvents | Guinea Pigs | Quaternary Ammonium Compounds - adverse effects | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Mice, Inbred C57BL | Quaternary Ammonium Compounds - therapeutic use | Aziridines - pharmacology | Mitochondria - metabolism | Interleukin-17 - biosynthesis | Mitochondria - drug effects | Cell Adhesion Molecules - metabolism | Animals | Embryo, Mammalian - cytology | Fibroblasts - drug effects | Multiple Sclerosis - pathology | Ligands | Mice | Synephrine - pharmacology | Multiple Sclerosis - drug therapy | Quaternary Ammonium Compounds - pharmacology | Complications and side effects | Multiple sclerosis | Corticosteroids | Nuclear magnetic resonance spectroscopy | Models | T cells | Apoptosis | Steroids | Nuclear magnetic resonance--NMR | Encephalomyelitis | Bcl-2 protein | Glucocorticoids | Neuropathology | Helper cells | Nervous system | Lymphocytes T | Alkylation | Medical schools | LFA-1 antigen | Magnetic resonance spectroscopy | Cell activation | Immunology | Blood-brain barrier | Lymphocytes | CD44 antigen | Rodents | Fibroblasts | Drug dosages | Deoxyribonucleic acid--DNA | Repressing | Myelin | Caspase | Inflammation | Metabolism | Gene expression | Experimental allergic encephalomyelitis | Interleukin 17 | Intermediates | Side effects | Brain research | NMR spectroscopy | Deoxyribonucleic acid | Nuclear magnetic resonance | NMR | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
by Jongen, Peter Joseph and Stavrakaki, Ioanna and Voet, Bernard and Hoogervorst, Erwin and van Munster, Erik and Linssen, Wim H and Sinnige, Ludovicus G and Verhagen, Wim I and Visser, Leo H and van der Kruijk, Ruud and Verheul, Freek and Boringa, Jan and Heerings, Marco and Gladdines, Werner and Lonnqvist, Freik and Gaillard, Pieter
JOURNAL OF NEUROLOGY, ISSN 0340-5354, 08/2016, Volume 263, Issue 8, pp. 1641 - 1651
In a prospective multi-center observational study, we evaluated the frequency, severity, and impact on activities of daily living (ADL) of adverse effects... 
Patient-reported | Neurology | Neurosciences | Multiple sclerosis | Medicine & Public Health | Methylprednisolone | High dose | Adverse effect | Neuroradiology | Side effect | EVENTS | RISK | CLINICAL NEUROLOGY | TRIAL | DISABILITY | STEROID-THERAPY | OUTCOMES | CORTICOSTEROIDS | IMPACT PROFILE MSIP | Prospective Studies | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Self Report | Male | Methylprednisolone - adverse effects | Activities of Daily Living | Disabled Persons - psychology | Dose-Response Relationship, Drug | Administration, Intravenous | Anti-Inflammatory Agents - adverse effects | Multiple Sclerosis, Relapsing-Remitting - psychology | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Surveys and Questionnaires | Aged | Online Systems - statistics & numerical data | Methylprednisolone - administration & dosage | Drugs | Complications and side effects | Care and treatment | Analysis | Adverse and side effects | Dosage and administration | Research | Health aspects | Original Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials
by Sciascia, Savino and Mompean, Elisa and Radin, Massimo and Roccatello, Dario and Cuadrado, Maria J
Clinical Drug Investigation, ISSN 1173-2563, 06/2017, Volume 37, Issue 6, pp. 519 - 524
Background and Objectives The efficacy of glucocorticoids (GCs) in treating systemic lupus erythematosus (SLE) is beyond doubt. However, GCs-related adverse... 
DOUBLE-BLIND | NEPHRITIS | PHARMACOLOGY & PHARMACY | PREDNISONE | CYCLOPHOSPHAMIDE | PULSE METHYLPREDNISOLONE | Lupus Erythematosus, Systemic - psychology | Hyperglycemia - chemically induced | Humans | Lupus Erythematosus, Systemic - drug therapy | Quality of Life | Glucocorticoids - adverse effects | Randomized Controlled Trials as Topic | Usage | Care and treatment | Corticosteroids | Systemic lupus erythematosus | Dosage and administration | Prednisone | Drug therapy | Lupus | Studies | Mortality | Medical Subject Headings-MeSH | Gangrene | Citation management software | Systematic review | Infections | Arthritis | Diabetes | Data bases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Adverse effects of corticosteroids on the cardiovascular system
by Sholter, Dalton E and Armstrong, Paul W
Canadian Journal of Cardiology, ISSN 0828-282X, 2000, Volume 16, Issue 4, pp. 505 - 511
OBJECTIVE: To review the potential adverse effects of glucocorticoid therapy on the cardiovascular system and to provide insight into the mechanisms of these... 
Hypertension | Lipids | Morbidity | Atherosclerosis | atherosclerosis | lipids | CORONARY-ARTERY DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | DOSE INTRAVENOUS METHYLPREDNISOLONE | LUPUS-ERYTHEMATOSUS | LOW-DENSITY LIPOPROTEIN | VASCULAR SMOOTH-MUSCLE | HEART-TRANSPLANT RECIPIENTS | ENDOTHELIAL-CELLS | ACUTE MYOCARDIAL-INFARCTION | HYDROCORTISONE-INDUCED HYPERTENSION | STEROID-THERAPY | morbidity | hypertension | Glucocorticoids - therapeutic use | Animals | Arrhythmias, Cardiac - chemically induced | Humans | Hypertension - chemically induced | Heart - drug effects | Thrombophilia - chemically induced | Heart Rupture, Post-Infarction - chemically induced | Hyperlipidemias - chemically induced | Glucocorticoids - adverse effects
Journal Article
Details down arrow
5. Full Text Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients
by Meaney, Calvin J and Arabi, Ziad and Venuto, Rocco C and Consiglio, Joseph D and Wilding, Gregory E and Tornatore, Kathleen M
BMC Nephrology, ISSN 1471-2369, 06/2014, Volume 15, Issue 1, pp. 88 - 88
Background: After renal transplantation, many patients experience adverse effects from maintenance immunosuppressive drugs. When these adverse effects occur,... 
Mycophenolic acid | Tacrolimus | Calcineurin inhibitors | Renal transplantation | Adverse effects | Cyclosporine | Immunosuppressive agents | METHYLPREDNISOLONE | NONCOMPLIANCE | THERAPY | SYMPTOM EXPERIENCE | PHARMACOKINETICS | DRUGS | UROLOGY & NEPHROLOGY | Severity of Illness Index | Reproducibility of Results | Risk Assessment | Brain Diseases - diagnosis | Calcineurin | Graft Rejection - prevention & control | Humans | Middle Aged | Gastrointestinal Diseases - classification | Graft Rejection - etiology | Male | Treatment Outcome | Graft Rejection - diagnosis | Gastrointestinal Diseases - diagnosis | Brain Diseases - chemically induced | Brain Diseases - classification | Sensitivity and Specificity | Female | Immunosuppressive Agents - adverse effects | Graft Survival - drug effects | Gastrointestinal Diseases - chemically induced | Kidney Transplantation - adverse effects | Medicine, Experimental | Medical research | Health care industry | Health aspects | Transplants & implants | Mortality | Nervous system | Pharmacology | Patients | Medicine | Confidence intervals | Validity | Pharmacy | Patient safety | Life sciences | Health risk assessment | Bioinformatics | Public health | Pharmaceutical sciences | Validation studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms
by Cengiz, FP and Su, O and Emiroglu, N and Biyik Ozkaya, D and Bahali, AG and Onsun, N
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, ISSN 0392-0488, 08/2019, Volume 154, Issue 4, pp. 488 - 491
Telaprevir is a specific inhibitor of the hepatitis C (HCV) serine protease 3. Cutaneous side effects have been reported with telaprevir. Drug reaction with... 
Drug hypersensitivity syndrome | DRESS | Telaprevir | RIBAVIRIN | Methylprednisolone | HEPATITIS-C | PEGINTERFERON | DERMATOLOGY
Journal Article
Details down arrow
7. Full Text Multitarget therapy for induction treatment of lupus nephritis: a randomized trial
by Liu, Zhihong and Liu, Zhihong and Zhang, Haitao and Zhang, Haitao and Liu, Zhangsuo and Liu, Zhangsuo and Xing, Changying and Xing, Changying and Fu, Ping and Fu, Ping and Ni, Zhaohui and Ni, Zhaohui and Chen, Jianghua and Chen, Jianghua and Lin, Hongli and Lin, Hongli and Liu, Fuyou and Liu, Fuyou and He, Yongcheng and He, Yongcheng and He, Yani and He, Yani and Miao, Lining and Miao, Lining and Chen, Nan and Chen, Nan and Li, Ying and Li, Ying and Gu, Yong and Gu, Yong and Shi, Wei and Shi, Wei and Hu, Weixin and Hu, Weixin and Liu, Zhengzhao and Liu, Zhengzhao and Bao, Hao and Bao, Hao and Zeng, Caihong and Zeng, Caihong and Zhou, Minlin and Zhou, Minlin
Annals of internal medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 1, pp. 18 - 26
Background: Treatment of lupus nephritis (LN) remains challenging. Objective: To assess the efficacy and safety of a multitarget therapy consisting of... 
MEDICINE, GENERAL & INTERNAL | PROSPECTIVE MULTICENTER | HISTOLOGIC DATA | CLINICAL-TRIALS | INTRAVENOUS CYCLOPHOSPHAMIDE | MISSING DATA | RENAL-TRANSPLANTATION | TACROLIMUS | MYCOPHENOLATE-MOFETIL | ERYTHEMATOSUS | CYCLOSPORINE | Glucocorticoids - therapeutic use | Prospective Studies | Kidney - pathology | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Lupus Nephritis - drug therapy | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Adult | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Lupus Nephritis - pathology | Prednisone - adverse effects | Tacrolimus - adverse effects | Remission Induction | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Pilot Projects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Biopsy | Adolescent | Immunosuppressive Agents - adverse effects | Aged | Prednisone - therapeutic use | Lupus | Complications and side effects | Drug targeting | Nephritis | Drug therapy | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
by Jones, Rachel B and Cohen Tervaert, Jan Willem and Hauser, Thomas and Luqmani, Raashid and Morgan, Matthew D and Peh, Chen Au and Savage, Caroline O and Segelmark, Mårten and Tesar, Vladimir and van Paassen, Pieter and Walsh, Michael and Walsh, Dorothy and Westman, Kerstin and Jayne, David R.W and European Vasculitis Study Grp and European Vasculitis Study Group and Linköpings universitet and Institutionen för medicin och hälsa and Hjärt- och Medicincentrum and Avdelningen för läkemedelsforskning and Östergötlands Läns Landsting and Njurmedicinska kliniken US and Hälsouniversitetet
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 211 - 220
A standard glucocorticoid regimen plus rituximab was not superior to standard intravenous cyclophosphamide as induction therapy in patients with newly... 
WEGENERS-GRANULOMATOSIS | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | MULTICENTER | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | EFFICACY | ACTIVE RHEUMATOID-ARTHRITIS | DOUBLE-BLIND | RANDOMIZED-TRIAL | REMISSION | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Incidence | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Murine-Derived | Glomerular Filtration Rate | Kidney Diseases - drug therapy | Rituximab | Kidney Diseases - mortality | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | B-Lymphocytes - drug effects | Intention to Treat Analysis | Immunosuppressive Agents - adverse effects | Aged | Infusions, Intravenous | Cyclophosphamide | Vasculitis | Research | Comparative analysis | Drug therapy | Clinical trials | Medical treatment | Mortality | Regulatory approval | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A comprehensive multimodal pain treatment reduces opioid consumption after multilevel spine surgery
by Mathiesen, Ole and Dahl, Benny and Thomsen, Berit A and Kitter, Birgitte and Sonne, Nan and Dahl, Jørgen B and Kehlet, Henrik
European Spine Journal, ISSN 0940-6719, 9/2013, Volume 22, Issue 9, pp. 2089 - 2096
Major spine surgery with multilevel instrumentation is followed by large amount of opioid consumption, significant pain and difficult mobilization in a... 
Mobilization | Surgical Orthopedics | Medicine & Public Health | Opioid consumption | Multimodal pain treatment | Major spine surgery | Neurosurgery | MORPHINE | FUSION SURGERY | METHYLPREDNISOLONE | TRENDS | CLINICAL NEUROLOGY | ISSUES | RECOVERY | TOTAL DISC REPLACEMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PLACEBO-CONTROLLED TRIAL | ORTHOPEDICS | Acetaminophen - adverse effects | Postoperative Nausea and Vomiting - chemically induced | Pain, Postoperative - drug therapy | Humans | Middle Aged | Acetaminophen - administration & dosage | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | gamma-Aminobutyric Acid - administration & dosage | Spinal Fusion - adverse effects | Case-Control Studies | Young Adult | Analgesics, Opioid - adverse effects | Analgesics, Non-Narcotic - adverse effects | Aged, 80 and over | Amines - administration & dosage | Adult | Antiemetics - adverse effects | Female | Amines - adverse effects | Drug Therapy, Combination | gamma-Aminobutyric Acid - adverse effects | Spinal Diseases - surgery | Dexamethasone - administration & dosage | Cyclohexanecarboxylic Acids - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Analgesics, Non-Narcotic - administration & dosage | Postoperative Nausea and Vomiting - drug therapy | Analgesics, Opioid - administration & dosage | Adolescent | Aged | Care and treatment | Pain | Corticosteroids | Anesthesia | Morphine | Nausea | Chronic pain | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
by Houssiau, Frédéric A and D'Cruz, David and Sangle, Shirish and Remy, Philippe and Vasconcelos, Carlos and Petrovic, Radmila and Fiehn, Christoph and de Ramon Garrido, Enrique and Gilboe, Inge-Magrethe and Tektonidou, Maria and Blockmans, Daniel and Ravelingien, Isabelle and le Guern, Véronique and Depresseux, Geneviève and Guillevin, Loïc and Cervera, Ricard and MAINTAIN Nephritis Trial Grp and MAINTAIN Nephritis Trial Group and the MAINTAIN Nephritis Trial Group
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2010, Volume 69, Issue 12, pp. 2083 - 2089
Background Long-term immunosuppressive treatment does not efficiently prevent relapses of lupus nephritis (LN). This investigator-initiated randomised trial... 
THERAPY | RHEUMATOLOGY | METHYLPREDNISOLONE | CYCLOPHOSPHAMIDE | ERYTHEMATOSUS | DISEASE-ACTIVITY | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Lupus Nephritis - drug therapy | Male | Treatment Outcome | Secondary Prevention | Cyclophosphamide - therapeutic use | Young Adult | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Adult | Female | Immunosuppressive Agents - adverse effects | Prednisolone - therapeutic use | Drug Therapy, Combination | Azathioprine - adverse effects | Nephritis | Safety and security measures | Patient outcomes | Dosage and administration | Research | Mycophenolate mofetil | Azathioprine | Drug therapy | Lupus | Pregnancy | Biopsy | Laboratories | Rodents | Blood pressure | Kidney diseases | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease
by Miura, M and Ohki, H and Yoshiba, S and Ueda, H and Sugaya, A and Satoh, M and Yamagishi, H
Archives of Disease in Childhood, ISSN 0003-9888, 10/2005, Volume 90, Issue 10, pp. 1096 - 1097
PEDIATRICS | Glucocorticoids - administration & dosage | Mucocutaneous Lymph Node Syndrome - drug therapy | Humans | Anticoagulants - therapeutic use | Heparin - therapeutic use | Methylprednisolone - adverse effects | Drug Therapy, Combination | Pulse Therapy, Drug | Glucocorticoids - adverse effects | Immunoglobulins, Intravenous | Methylprednisolone - administration & dosage | Complications and side effects | Kawasaki disease | Drug therapy | Methylprednisolone | Letter
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Pneumonitis: A serious adverse effect of PD-L1 inhibitors including pembrolizumab
by Rickard, Frances and Hyams, Catherine and Low, Andrew T
BMJ Case Reports, ISSN 1757-790X, 2018, Volume 2018, p. bcr-2018-224485
A 70-year-old man presented with breathlessness, cough and fever while receiving pembrolizumab for melanoma. A CT pulmonary angiogram demonstrated small... 
skin cancer | malignant disease and immunosuppression | immunological products and vaccines | contraindications and precautions | drugs: respiratory system | Antineoplastic Agents, Immunological - administration & dosage | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Pneumonia - pathology | Cough - diagnosis | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Dyspnea - etiology | Pulmonary Embolism - pathology | Continuous Positive Airway Pressure - methods | Antibodies, Monoclonal, Humanized - administration & dosage | Computed Tomography Angiography - methods | Pneumonia - chemically induced | Fatal Outcome | Pulmonary Embolism - diagnostic imaging | Antibodies, Monoclonal, Humanized - adverse effects | Pulmonary Embolism - complications | Diagnosis, Differential | Intensive Care Units | Antibodies, Monoclonal, Humanized - therapeutic use | Dyspnea - diagnosis | Hypoxia - complications | Melanoma - pathology | Cough - etiology | Antineoplastic Agents, Immunological - adverse effects | Pneumonia - drug therapy | Antineoplastic Agents, Immunological - therapeutic use | Melanoma - drug therapy | Pneumonia - complications | Pulmonary Embolism - drug therapy | Aged | Methylprednisolone - administration & dosage | Pneumonia | Pulmonary arteries | Weaning | Lung cancer | Melanoma | Oncology | Family medical history | Metastasis | Patients | Cancer therapies | Skin cancer | Chemotherapy | Medical prognosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
by Stone, John H and Merkel, Peter A and Spiera, Robert and Seo, Philip and Langford, Carol A and Hoffman, Gary S and Kallenberg, Cees G.M and St. Clair, E. William and Turkiewicz, Anthony and Tchao, Nadia K and Webber, Lisa and Ding, Linna and Sejismundo, Lourdes P and Mieras, Kathleen and Weitzenkamp, David and Ikle, David and Seyfert-Margolis, Vicki and Mueller, Mark and Brunetta, Paul and Allen, Nancy B and Fervenza, Fernando C and Geetha, Duvuru and Keogh, Karina A and Kissin, Eugene Y and Monach, Paul A and Peikert, Tobias and Stegeman, Coen and Ytterberg, Steven R and Specks, Ulrich and RAVE-ITN Res Grp and RAVE-ITN Research Group
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 221 - 232
This multicenter, randomized, double-blind, double-dummy, noninferiority trial compared rituximab with cyclophosphamide for remission induction in... 
WEGENERS-GRANULOMATOSIS | B-CELLS | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | RANDOMIZED-TRIAL | GRANULOMATOSIS ETANERCEPT TRIAL | SYSTEMIC VASCULITIDES | INDUCTION | CELL-ACTIVATION | REMISSION | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Murine-Derived | Double-Blind Method | Administration, Oral | Rituximab | Remission Induction | B-Lymphocytes - drug effects | Intention to Treat Analysis | Microscopic Polyangiitis - drug therapy | Quality of Life | Granulomatosis with Polyangiitis - drug therapy | Immunosuppressive Agents - adverse effects | Aged | Neoplasms - epidemiology | Prednisone - therapeutic use | Antibodies, Antineutrophil Cytoplasmic - blood | Autoantibodies | Vasculitis | Research | Comparative analysis | Drug therapy | Patient outcomes | Disease | Clinical trials | Lymphocytes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Side effects of medications used to treat childhood interstitial lung disease
by Breuer, Oded and Schultz, André
Paediatric Respiratory Reviews, ISSN 1526-0542, 09/2018, Volume 28, pp. 68 - 79
Interstitial lung disease in children (chILD) comprises a range of different rare diseases. There is limited evidence for the treatment of chILD and no... 
Hydroxychloroquine | Medication side effects | Interstitial lung disease in children (chILD) | Prednisolone | Azithromycin | Pulse methylprednisolone | SURFACTANT PROTEIN-C | MANAGEMENT | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | PREVENTION | CHLOROQUINE TREATMENT | CHILDREN | RESPIRATORY SYSTEM | PEDIATRICS | Prednisolone - adverse effects | Off-Label Use | Humans | Methylprednisolone - adverse effects | Hydroxychloroquine - adverse effects | Cyclophosphamide - adverse effects | Lung Diseases, Interstitial - drug therapy | Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects | Azithromycin - adverse effects | Methotrexate - adverse effects | Antirheumatic Agents - adverse effects | Immunosuppressive Agents - adverse effects | Anti-Bacterial Agents - adverse effects | Child | Glucocorticoids - adverse effects | Rituximab - adverse effects | Complications and side effects | Corticosteroids | Drugs and youth | Lung diseases | Children's hospitals | Children | Drug therapy | Methylprednisolone | Diseases
Journal Article
Details down arrow